Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.68498 | 29 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.56411 | 24 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.61138 | 27 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.582 | 28 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.58541 | 28 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.64876 | 25 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.61439 | 25 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.59106 | 26 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.59384 | 27 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.55631 | 24 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.59202 | 26 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.59712 | 27 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.60995 | 27 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.60106 | 26 |